Korea Pharma Co (XKRX:032300) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 31, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Korea Pharma Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Korea Pharma Co's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Korea Pharma Co's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Korea Pharma Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Korea Pharma Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Korea Pharma Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Korea Pharma Co's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Korea Pharma Co (XKRX:032300) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Korea Pharma Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Korea Pharma Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Korea Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Pharma Co Ltd (XKRX:032300) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Traded in Other Exchanges

N/A

Address

8th Floor, 14, Teheran-ro 4-gil, Gangnam-gu, Seoul, KOR

Website

http://www.koreapharma.co.kr

Korea Pharma Co Ltd is a drug manufacturer. The company's products include amino acid drugs; antibiotic drugs; antidotal drugs; antiepileptic drugs; antihistamine drugs; anti-inflammatory drugs; antimicrobial drugs; antiplatelet drugs; circulatory system drugs; cns drugs; dermatological drugs; endocrine drugs; gastrointestinal drugs; hepatic drugs; hormonal drugs; multivitamins; respiratory drugs; skeltal muscle relaxants; specialty drugs; sympathomimetic drugs; and vitamin b1.

Korea Pharma Co Headlines

No Headlines